Sylvamo Corp (SLVM)
Valuation Overview•Is Sylvamo Corp Overvalued or Undervalued?
Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Fragile underlying quality score of 43/100; weak margins or elevated debt leverage warrant caution.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Average quality business weighed down by significant growth concerns.
Wall Street is highly bullish, projecting significant upside. This outlook is strongly supported by highly attractive capital returns, driven by a balanced mix of reliable dividends and share buybacks.
SLVM struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company is facing top-line contraction (-2.6% 3Y CAGR) paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 5.9%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $806.0M | -11.2% | -2.6% | +7.0% | — | |
| EBITDA | $57.0M | — | -12.6% | — | — | |
| Net Income | -$11.0M | -56.3% | +3.8% | — | — | |
| EPS (Diluted) | $-0.28 | -55.2% | +6.6% | -3.5% | — | |
| Free Cash Flow | $87.0M | -82.3% | -46.6% | -31.1% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 20.4% | 23.8% | 24.7% | 25.3% |
| Operating Margin | 5.9% | 10.0% | 11.3% | 10.4% |
| Net Margin | 2.3% | 6.2% | 6.7% | 7.2% |
| FCF Margin | 3.0% | 5.3% | 8.1% | 9.0% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q3'26Latest | $0.02 | $0.03 | +71.4% | ||
| Q2'26 | $-0.25 | $-0.53 | -112.0% | ||
| Q1'26 | $1.05 | $1.08 | +2.9% | ||
| Q4'25 | $1.57 | $1.44 | -8.3% | ||
| Q3'25 | $0.47 | $0.37 | -21.3% | ||
| Q2'25 | $0.70 | $0.68 | -2.9% | ||
| Q1'25 | $1.84 | $1.94 | +5.4% | ||
| Q4'24 | $2.18 | $2.44 | +11.9% |
Total return is -11.4% (1Y), lagging the benchmark by -27.2%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -20.5% | -32.9% | — |
| 1Y | -11.4% | -27.2% | +4.1% |
| 3YCAGR | -1.6% | -21.3% | +12.0% |
| 5YCAGR | +11.4% | -0.1% | +24.9% |
| 10YCAGR | +5.5% | -7.9% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Sylvamo Corp (SLVM) valuation, health, and returns.
Sylvamo Corp is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Limited: Cheap versus peers compared to industry peers. trading near fair value (DCF: $36.37)
Sylvamo Corp has multiple valuation anchors: DCF Intrinsic Value: $36.37 | Peer Relative Fair Value: $54.10 | Wall Street Analyst Target: $48.67 (implying +32.8% upside). A convergence of these signals offers higher conviction.
Sylvamo Corp displays fair financial health with a composite quality score of 43/100, supported by a Altman Z-Score of 2.9 (grey zone), Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of 11.9%.
Sylvamo Corp pays a 4.9% dividend yield, covered by a 55% payout ratio with 4 years of growth, supplemented by a 5.6% buyback yield.
Sylvamo Corp's current growth trajectory is Decelerating. The company achieved -11.2% 1Y revenue growth and -55.2% 1Y EPS growth, compared to its 3Y revenue CAGR of -2.6%.
Wall Street consensus is Buy based on 2 analysts, beating EPS expectations in 67% of recent quarters with a 1-quarter streak. The consensus price target represents a +32.8% change from current levels.
Investment risks for Sylvamo Corp include: -36.9% 1-year max drawdown. Volatility risk is characterized by a beta of 0.70x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.